Janssen’s Ponvory Will Face Stiff Competition In Europe’s MS Market

Approved In The EU For RMS

multiple sclerosis
• Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Neurological

More from Therapy Areas